BDBM580883 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N,N- dimethylazetidine-1-carboxamide::US11492348, Compound 95

SMILES CN(C)C(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1

InChI Key InChIKey=HHRCZUVDMACSEU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 580883   

TargetRAC-alpha serine/threonine-protein kinase [1-472,474-480](Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM580883(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)...)
Affinity DataIC50:  5.19E+3nMAssay Description:Inhibition of the PI3K-AKT-mTOR pathway was measured by quantifying the loss of (Ser-473) pAKT using AlphaScreen (Perkin Elmer). B103 (Rat Neuroblast...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM580883(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)...)
Affinity DataIC50:  120nMAssay Description:Quantification of ATP to ADP conversion as a measure of PI3Kα activity. Active PI3Kα (Life Technologies), in the presence or absence of PI3...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent